According to Zhitong Finance App, China Resources Pharmaceutical (03320) announced that on July 21, 2026, China Resources Pharmaceutical Holdings Co., Ltd. (China Resources Pharmaceutical Holdings), a wholly-owned subsidiary of the Company, has completed issuing the first issue of 2026 medium-term notes (the first 2026 medium-term note) in China. The first 2026 medium-term note with a principal amount of RMB 1 billion has been issued. The term is three years, and the coupon interest rate is 1.53% per annum. The funds raised from the issuance of the first 2026 medium-term notes will be used to supplement working capital, repay interest-bearing debts, and other purposes in accordance with applicable laws and regulations.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.